catheter from the femoral artery or femoral venous side according to the site of the lesion. A basic electrophysiology study was performed and arrhythmia inducibility determined in each patient, using standard atrial and ventricular rapid pacing and extrastimulation. If arrhythmia could not be induced with the standard protocol, isoproterenol infusion was given to enhance inducibility. Only after the tachycardia was induced would RFCA be performed. The size of the catheters ranged from 4 to 6 French. Biplane fluoroscopy was used for localization during mapping and ablation. After localization, RFCA energy was delivered through ablation catheters. For those with a left-sided accessory pathway, a retrograde trans-aortic approach was adopted, but in 1 patient with left-sided AT, a transatrial septal approach was used. We used the temperature-control mode with the highest temperature limit range from 60°C to 65°C and the highest energy given at 50 W. The therapeutic endpoint was non-inducibility of tachycardia and equal to or less than 1 echo beat after isoproterenol infusion for reentrant tachycardia involving dual AV nodal pathways or twin AV nodes. Overnight heparinization was given for left-sides lesions and single ventricle disease, followed by aspirin 3-5 mg/kg once daily for 2 more weeks. Patients were not discharged for a further day to check if any arrhythmia recurrence or complications occurred. Patients were then evaluated at outpatient clinics.
At follow-up, any cardiac symptoms, including palpitation, chest discomfort, and near-syncope episodes, were recorded, and a physical examination, including cardiac auscultation, was done by a cardiologist. Electrocardiography was performed every 6-12 months, and echocardiography was performed if there were any positive findings on the physical examination. For those who were lost to follow-up for more than 2 years, we used a telephone interview to evaluate their current clinical status and recorded any documented tachycardia events.
Statistical Analysis
For comparative analysis, because of the relatively small number of patients, non-parametric statistics were used. Mann-Whitney test was used for numerical data comparison, and chi-square test or Fischer's exact test was used for categorical data comparison. Clinical significance was defined as P<0.05.
Results

Tachycardia Mechanisms and Acute Results of Ablation
Basic clinical characteristics of the patients are shown in Table 1 . The mean age was 3.9 years and mean body weight was 16.2 kg at the time of RFCA. The male/female ratio was 17/10. The types of SVT are also shown in Table 1 . AVRT either through a concealed or manifest accessory pathway was found in 15 patients: 8 had a leftsided lesion and 7 were right-sided. AT or atrial flutter (AFl) was found in 5 patients, AVNRT in 2, twin atrioventricular nodal tachycardia (TAVNT) in 2 and multiple mechanism arrhythmia in 3. Of those with multiple mechanism arrhythmia, 1 had combined AVNRT and AT, 1 had combined TAVNT and AFl, and 1 had 3 types of arrhythmia: AVNRT, AVRT and AFl. Of the 27 patients, 9 (33.3%) had associated congenital heart disease: 3 had a repaired ventricular septal defect (2 had AFl and 1 had AVRT because of a right posteroseptal accessory pathway) and 6 had heterotaxy syndrome with right isomerism and complex congenital heart disease (3 had TAVNT, 1 had AVNRT and 2 had intra-atrial reentry tachycardia).
Electrophysiology study and RFCA were performed in all 27 patients, using 2 catheters only in 4, 3 catheters in 1 and 4-6 in 22 patients. All patients who had less than 4 catheters used during the electrophysiology study and ablation had a body weight less than 15 kg. The tachycardia foci were ablated mechanically during catheter manipulation in 2 patients: 1 with intra-atrial reentry tachycardia and the other one with AVRT with a right posteroseptal accessory pathway that was subsequently ablated by RF energy booster. Neither had had recurrence of arrhythmia at 5.4 and 8.1 years follow-up. For the other 25 patients undergoing RFCA, success was achieved in 23 patients, giving a success rate of 92.6%. As for the 2 patients with a failed RFCA procedure, 1 with a repaired ventricular septal defect had incessant AFl that was converted to sinus rhythm by direct current cardioversion, and the other had intractable AVRT because of a left posteroseptal accessory pathway. As for the 3 patients with multiple types of SVT, only the clinical arrhythmia was ablated at the first attempt: AFl/ AVRT, AT and TAVNT were ablated leaving the AVNRT alone in 2 patients because of the potential risk and the family's choice. In these 3 patients, 2 had arrhythmia recurrences that were documented as AVNRT by repeat electrophysiological study and then controlled medically.
Two complications occurred during the RFCA procedures. The first patient was a boy with a concealed paraHisian accessory pathway with frequent and drug-refractory AVRT presenting as cardiomegaly, shock, and heart failure since infancy. He underwent a electrophysiological study and RFCA at the age of 5 years. At energy delivery, he suffered from high-degree AV block. Although the energy was discontinued immediately, he still developed complete AV block and received a permanent transvenous VDD pacemaker. The other patient was a girl with AVRT because of a concealed left lateral accessory pathway presenting with neurologic symptoms of left hemiparesis. She underwent RFCA at the age of 3 years. After energy delivery for 30 s, the accessory pathway was eliminated. On continuation of energy delivery, sudden-onset bradycardia developed with a junction escape rhythm. Energy was stopped immediately. The bradycardia lasted for 10 s and recovered gradually ( Figure) . It was attributed to Bezold-Jarisch reflex. Because of this complication, no further booster energy was given. AVRT recurred 3.8 years later and repeat electrophysiology showed the same left lateral accessory pathway. She underwent another RFCA that successfully eliminated the accessory pathway.
Tachycardia-Induced Cardiomyopathy
Four (14.8%) underwent RFCA because of tachycardia cardiomyopathy ( Table 2) : 2 with AT/AFl and 2 with AVRT. Acute success with RFCA was achieved in all, but 1 patient had a recurrence at 1 month after the ablation. He then had another RFCA 6 months later, which eliminated the accessory pathway. The heart failure resolved after successful RFCA in all. Cardiomegaly on chest X-ray recovered and cardiac function on echocardiography returned to normal after a median of 13 days after successful RFCA.
Late Outcomes
During 1-13 years (mean 5.4 years) follow-up, 3 (11%) patients had tachycardia recurrence at 0.1-5.8 years after RFCA ( Table 3 ). The patient with early recurrence had a right lateral accessory pathway and tachycardia cardiomyopathy (described earlier). With the other 2 patients with late recurrence, 1 had concealed AVRT with left lateral accessory pathway (the patient who developed BezoldJarisch reflex) and 1 had scar-related intra-atrial reentry tachycardia that was controlled medically after the recurrence. None had new arrhythmias noted. The left ventricu-
Sudden onset of bradycardia during energy delivery for left lateral concealed accessory pathway lasted approximately 10 s. Bezold-Jarisch is considered to be the possible mechanism. lar function in all, including the patient with a permanent VDD pacemaker after ablation of a para-Histian accessory pathway and those with tachycardia cardiomyopathy, was all within normal limits.
Risk Analysis
The outcomes, including the acute access rate, complication rates and recurrence, were not associated with the age and body weight at RFCA, the presence of congenital heart disease, or the mechanism of arrhythmia. Subgroup analysis of patients weighing less than and more than 15 kg revealed no significant differences in the success rate, complication rate or recurrence rate (P=1.000, 0.367, and 0.155, respectively).
Discussion
From this study of RFCA of tachycardia in children under the age of 6 years, we have the following main findings: (1) the mechanism of tachycardia that required RFCA was mostly AVRT, sometimes AT and rarely AVNRT and TAVNT, (2) tachycardia cardiomyopathy was observed in approximately one-sixth of the patients and could be improved to normal after successful RFCA, and (3) the acute success, even with a limited number of applied catheters, could be achieved in more than 90% of the patients.
In the pediatric RFCA registry data from 1991 to 1997, a significant risk of complications during RFCA, including AV block, cardiac perforation and even death, was body weight at procedure of less than 15 kg. 13 The ablation zone of AVNRT is reported to be smaller in younger children. 16 In an animal study of newborn lambs the RFCA lesion increased with age, 17 so aggressive medical control including class Ic and III antiarrhythmia agents has been suggested for this age group. 18 However, several recent studies have shown promising results of RFCA for SVT in young children. 11, 14 In the present study, the proportion of patients with AT (18.5%), congenital heart disease and multiple mechanisms of SVT (11.1%), which may increase the difficulties of RFCA, was relatively high. 19, 20 Nonetheless, the acute success rate (92.6%), major complication rate (3.7%), and recurrence rate (13%) were all comparable to those in our previous report on the whole pediatric population and in other pediatric reports. 1, 3, [11] [12] [13] [14] 21 The presence of congenital heart disease was not associated with worse outcomes, but this should be interpreted with caution. Most of our patients with congenital heart disease requiring RFCA at such a young age had congenital heart disease other than Ebstein's anomaly, which is notoriously associated with lower success rates and higher recurrence rates. 20 Instead, over half of our patients had right atrial isomerism and underwent RFCA before the planned operation of total cavopulmonary connection. Such unique TAVNT had been described in our previous reports and by others as well. [22] [23] [24] Because the venous access may be limited after total cavopulmonary connection, RFCA is recommended before the operation in those who have clinical tachycardia or tachycardia during cardiac catheterization. The results as shown in our studies were satisfactory.
In smaller children, the whole RFCA procedure may be completed using fewer mapping catheters, as shown in this study. In young children, because of the relatively small caliber of their vessels, vascular access is often a problem during transcatheter intervention. In addition, vascular injury or even total occlusion is a common complication of transcatheter intervention in the young population. 25, 26 In our study, 5 of 27 patients who had a body weight less than 15 kg had only 1 or 2 catheters used for mapping and only 1 for ablation during the whole procedure. Acute success was achieved in all except for the 1 with scar-related AT. None had recurrence during follow-up. Therefore, in young children weighing less than 15 kg, RFCA can still be completed with satisfactory results by using a limited number of catheters.
Tachycardia cardiomyopathy is another common indication for RFCA secondary to drug refractoriness, which often occurs in cases of incessant SVT and can occur if tachycardia persists for 48 h. 27 The most common form of SVT in tachycardia cardiomyopathy includes permanent junctional reciprocating tachycardia and atrial arrhythmia. In some instances, AVRT, most commonly a septal accessory pathway, may cause incessant tachycardia and cause tachycardia cardiomyopathy. 28, 29 In our patients with tachycardia cardiomyopathy, 2 had AT, and 1 had a septal accessory pathway. The last patient, however, had a right lateral accessory pathway that resulted in AVRT. Although not incessant, the tachycardia attacks were very frequent. After successful RFCA, their symptoms of heart failure and cardiomegaly resolved gradually. Cardiac function remained normal over the long-term follow-up. Therefore, RFCA should be considered in pediatric patients who have tachycardia and associated dilated cardiomyopathy although the association may be difficult to define.
As to complications of RFCA in such a young age group, the only major complication in our study was complete AV block after RFCA in 1 patient with a para-Hisian accessory pathway. Because of the relatively narrow safety zone in small children, it is not suggested that RFCA for AVNRT or para-Hisian accessory pathway be performed in young patients. 30 Cryoablation, instead of radiofrequency ablation, may be a good alternative to avoid such complications. 31 We also had another patient who developed profound bradycardia during ablation of a left lateral accessory pathway, which was attributed to Bezold-Jarisch reflex. It has been reported in adult patients receiving ablation of a left-sided accessory pathway or left atrial arrhythmia foci, presumably CHD, congenital heart disease; AVRT, atrioventricular reentry tachycardia; RAI, right atrial isomerism; DORV, double outlet right ventricle. Other abbreviations as in Table 1. because of stimulation of either nearby vagal afferent pathways or sensory terminal receptors. 32, 33 It is self-limiting, and sometimes atropine can be used to reverse the bradycardia and hypotension. This is the first case report in small children, and should be kept in mind because higher vagal tone is common in them.
Though possible arrhythmia foci after RFCA are a concern in small children, none of our patients had new onset arrhythmia after RFCA after long-term follow-up. 17 In addition, none had significant valvular regurgitation after RFCA during follow-up in the clinics. Therefore, by meticulous mapping and careful manipulation of catheters, complications such as valvular damage or late scar-related arrhythmias may be avoided.
Conclusion
RFCA for SVT in children less than 6 years of age is feasible and can be completed with limited venous access and number of catheters. The acute success and long-term outcomes are comparable to those in older pediatric age groups. It should be considered as a treatment choice in those with medically refractory SVT or tachycardia cardiomyopathy. However, for those with AVNRT or a para-Hisian accessory pathway, conservative treatment is still recommended to avoid potential complications in younger patients.
